RecruitingNot ApplicableNCT06122064

A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer

Shared Decision-Making Encounter Tool for Adjuvant Treatment of Lung Cancer: Randomized Control Trial


Sponsor

Mayo Clinic

Enrollment

100 participants

Start Date

Nov 20, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical trial compares the use of a shared decision-making communication tool during a clinical encounter to standard care for improving the quality of the shared decision-making process among patients with non-small cell lung cancer. Lung cancer patients are faced with many decisions about their treatment options. Studies have found that patients are most satisfied if they perceive an effort by their physician to share decision making and are afforded sufficient time to make their decision. Shared decision-making tools can help physicians guide the conversation, offer tailored estimates of the potential benefits, harms, and practical inconveniences of the available options, and support deliberations that take into account patient biological and biographical circumstances, goals, and priorities. Incorporating a shared decision-making communication tool into standard clinical encounters may improve the shared-decision making process as well as patient satisfaction with their treatment choice.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests a new digital tool designed to help doctors and patients with non-small cell lung cancer (NSCLC) make treatment decisions together — a process called shared decision-making. Researchers want to see if the tool improves communication and satisfaction with treatment choices. **You may be eligible if...** - You are a clinician (doctor, nurse practitioner, or physician assistant) in participating departments at Mayo Clinic in Rochester, OR - You are an adult patient (18 or older) with non-small cell lung cancer stage 1B or higher, seen at Mayo Clinic in Rochester - You are eligible for adjuvant treatment (treatment after surgery) as determined by your oncologist **You may NOT be eligible if...** - You are a patient with major barriers to participating in discussions about your treatment (such as severe dementia, serious hearing loss, or severe visual impairment) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBest Practice

Receive standard of care

OTHERCommunication Intervention

Use shared decision-making conversation tool

OTHERElectronic Health Record Review

Ancillary studies

OTHERSurvey Administration

Ancillary studies

OTHERVideo Recording

Ancillary studies

OTHERAudio Recording

Ancillary studies


Locations(1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06122064


Related Trials